Nice!
I'll take 86% - feels about right to me
"By the end of the year,Paradigm Biopharmaceuticals (ASX: PAR)is due to report on a Phase 2/3 trial for its repurposed drug to treat knee osteoarthritis.
The algo ascribes a high success probability of just under 86 per cent, partly because of the high enrolment of 900 patients.
"
Nice!I'll take 86% - feels about right to me"By the end of the...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $71.79M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.5¢ | 19.5¢ | $30.86K | 152.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 71997 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 16142 | 3 |
View Market Depth
| Last trade - 11.39am 02/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |